Package 25682-025-01

Brand: ultomiris

Generic: ravulizumab
NDC Package

Package Facts

Identity

Package NDC 25682-025-01
Digits Only 2568202501
Product NDC 25682-025
Product ID 25682-025_41262953-a849-4095-b9c2-5a1d8b0238cc
Description

1 VIAL, GLASS in 1 CARTON (25682-025-01) / 3 mL in 1 VIAL, GLASS

Marketing

Marketing Status
Marketed Since 2020-10-09
Brand ultomiris
Generic ravulizumab
Sample Package No

Linked Drug Pages (1)

Ultomiris ndc-match (0.95)

Raw FDA Data

View complete raw FDA NDC JSON payload 
{"route": ["INTRAVENOUS"], "spl_id": "41262953-a849-4095-b9c2-5a1d8b0238cc", "openfda": {"nui": ["N0000175575", "N0000175974"], "unii": ["C3VX249T6L"], "rxcui": ["2107320", "2107325", "2461134", "2461136", "2461139", "2461140"], "spl_set_id": ["a9a590d9-0217-43c7-908d-e62a71279791"], "pharm_class_epc": ["Complement Inhibitor [EPC]"], "pharm_class_moa": ["Complement Inhibitors [MoA]"], "manufacturer_name": ["Alexion Pharmaceuticals Inc."], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "1 VIAL, GLASS in 1 CARTON (25682-025-01)  / 3 mL in 1 VIAL, GLASS", "package_ndc": "25682-025-01", "marketing_start_date": "20201009"}], "brand_name": "Ultomiris", "product_id": "25682-025_41262953-a849-4095-b9c2-5a1d8b0238cc", "dosage_form": "SOLUTION, CONCENTRATE", "pharm_class": ["Complement Inhibitor [EPC]", "Complement Inhibitors [MoA]"], "product_ndc": "25682-025", "generic_name": "ravulizumab", "labeler_name": "Alexion Pharmaceuticals Inc.", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Ultomiris", "active_ingredients": [{"name": "RAVULIZUMAB", "strength": "300 mg/3mL"}], "application_number": "BLA761108", "marketing_category": "BLA", "marketing_start_date": "20201009", "listing_expiration_date": "20261231"}